Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage

被引:6
|
作者
Chen, Chuan-Shu [1 ,2 ]
Lin, Chia-Yen [1 ,2 ,3 ]
Wang, Chun-Li [4 ]
Wang, Shian-Shiang [1 ,2 ,5 ]
Li, Jian-Ri [2 ]
Yang, Chun-Kuang [2 ]
Cheng, Chen-Li [2 ]
Chiu, Kun-Yuan [2 ,5 ]
Yang, Shun-Fa [1 ,6 ]
机构
[1] Chung Shan Med Univ, Inst Med, Taichung, Taiwan
[2] Taichung Vet Gen Hosp, Div Urol, Dept Surg, Taichung, Taiwan
[3] Taichung Vet Gen Hosp, Div Surg Crit Care, Dept Crit Care Med, Taichung, Taiwan
[4] Taichung Vet Gen Hosp, Dept Family Med, Taichung, Taiwan
[5] Natl Chi Nan Univ, Dept Appl Chem, Nantou, Taiwan
[6] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan
关键词
Urothelial carcinoma; Upper tract; Node negative; Nephroureterectomy; Survival; Lymphovascular invasion; RADICAL NEPHROURETERECTOMY; PROGNOSTIC VALUE; ADJUVANT CHEMOTHERAPY; DISSECTION;
D O I
10.1016/j.urolonc.2020.08.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To evaluate the prognostic impact of lymphovascular invasion (LVI) on node-negative upper tract urothelial carcinoma (UTUC) in patients treated with radical nephroureterectomy (RNU). Materials and methods: A retrospective study was performed in single tertiary referral center of middle Taiwan between 2001 and 2015. Seven hundred and twenty-eight patients were diagnosed of UTUC and underwent RNU with ipsilateral bladder cuff excision including 303 and 195 patients with N0 and Nx status respectively. LVI status was assessed as a prognostic factor for cancer-specific (CSS) and overall survival (OS) using univariate and multivariate Cox regression analysis. Results: LVI was observed in 82 patients (16.5%). LVI presentation associated with smoking status, advanced tumor stage, high tumor grade, positive surgical margin, and consequence lung/liver/bone metastasis. In the multivariate analysis, LVI was failed to predict CSS, OS, and disease-free survival (DFS) (hazard ratio [HR] [95% confidence interval [CI]: 1.07 [0.55-2.09], 1.05 [0.62-1.79], 1.15 [0.69-1.92], in CSS, OS, DFS, respectively). In the subgroup analysis of pT1-2 disease, the CSS, OS, and DFS were associated with LVI status (HR [95% CI]: 2.29 [0.44-11.84], 3.17 [1.16-8.67], 2.66 [1.04-6.79], in CSS, OS, DFS, respectively). In contrast, there was no difference in pT3 disease. Conclusion: In conclusion, LVI status was not associated with survival outcomes of node-negative UTUC in our study. The subgroup analysis showed different prognostic impacts of LVI status in node-negative UTUC with T1-2 and T3 stage. Further evidence to clarify the prognostic effect is needed to make LVI became a practical factor in clinical decision-making. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:132.e13 / 132.e26
页数:14
相关论文
共 50 条
  • [31] Is Lymph Node Dissection Necessary During Radical Nephroureterectomy for Clinically Node-Negative Upper Tract Urothelial Carcinoma? A Multi-Institutional Study
    Lee, Hsiang-Ying
    Chang, Chao-Hsiang
    Huang, Chi-Ping
    Yu, Chih-Chin
    Lo, Chi-Wen
    Chung, Shiu-Dong
    Wu, Wei-Che
    Chen, I-Hsuan Alan
    Lin, Jen-Tai
    Jiang, Yuan-Hong
    Lee, Yu-Khun
    Hsueh, Thomas Y.
    Chiu, Allen W.
    Chen, Yung-Tai
    Lin, Chang-Min
    Tsai, Yao-Chou
    Chen, Wei-Chieh
    Chiang, Bing-Juin
    Huang, Hsu-Che
    Chen, Chung-Hsin
    Huang, Chao-Yuan
    Wu, Chia-Chang
    Lin, Wei Yu
    Tseng, Jen-Shu
    Ke, Hung-Lung
    Yeh, Hsin-Chih
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [32] ASSOCIATION OF SOCIOECONOMIC DISADVANTAGE AND INSURANCE TYPE WITH ONCOLOGICAL OUTCOMES IN UPPER TRACT UROTHELIAL CARCINOMA
    Moghaddam, Farshad Sheybaee
    Ghoreifi, Alireza
    Chun, Jessica
    Sobhani, Sina
    Udov, Andrew
    Nabhani, Jamal
    Djaladat, Hooman
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1130 - E1130
  • [33] Concomitant carcinoma in situ is an independent prognostic predictor for patients with localized lymph node-negative upper-tract urothelial carcinoma undergoing nephroureterectomy
    Cheng, Pai-Yu
    Chung, Shiu-Dong
    Tsai, Chung-You
    JOURNAL OF CLINICAL UROLOGY, 2023, 16 (04) : 325 - 332
  • [34] Lymphovascular invasion as a prognostic factor in the upper urinary tract urothelial carcinoma: A systematic review and meta-analysis
    Ku, Ja Hyeon
    Byun, Seok-Soo
    Jeong, Hyeon
    Kwak, Cheol
    Kim, Hyeon Hoe
    Lee, Sang Eun
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (12) : 2665 - 2680
  • [35] Preoperative sarcopenia status is associated with lymphovascular invasion in upper tract urothelial carcinoma patients treated with radical nephroureterectomy
    Anno, Tadatsugu
    Kikuchi, Eiji
    Fukumoto, Keishiro
    Ogihara, Koichiro
    Oya, Mototsugu
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2018, 12 (03): : E132 - E136
  • [36] HIGH RISK UPPER URINARY TRACT UROTHELIAL CARCINOMA PATIENTS WITH LYMPHOVASCULAR INVASION HAVE THE ADVANTAGE OF ADJUVANT CHEMOTHERAPY
    Yamashita, Shinichi
    Ito, Akihiro
    Shintaku, Ichiro
    Tochigi, Tatsuo
    Soma, Fumihiko
    Namima, Takashige
    Katoh, Shinnosuke
    Ota, Shozo
    Kyan, Atsushi
    Orikasa, Kazuhiko
    Numahata, Kenji
    Takeda, Atsushi
    Aizawa, Masataka
    Ioritani, Naomasa
    Kaiho, Yasuhiro
    Nakagawa, Haruo
    Arai, Yoichi
    JOURNAL OF UROLOGY, 2015, 193 (04): : E18 - E18
  • [37] The prognostic impact of lymphovascular invasion for upper urinary tract urothelial carcinoma: A propensity score-weighted analysis
    Chang, Yin Lun
    Chen, Yen Ta
    Wang, Hung Hen
    Chiang, Po Hui
    Cheng, Yuan Tso
    Kang, Chih Hsiung
    Chuang, Yao Chi
    Lee, Wei Chin
    Yang, Wen Chou
    Liu, Hui Ying
    Su, Yu Li
    Huang, Chun Chieh
    Tse, Sung Min
    Luo, Hao Lun
    MEDICINE, 2023, 102 (15) : E33485
  • [38] The association between gender and outcome of patients with upper tract urothelial cancer
    Chou, Yii-Her
    Chang, Wei-Chiao
    Wu, Wen-Jeng
    Li, Ching-Chia
    Yeh, Hsin-Chih
    Hou, Ming-Feng
    Chou, Ping-Song
    Lee, Mei-Hui
    Chang, Wei-Pin
    Li, Wei-Ming
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2013, 29 (01): : 37 - 42
  • [39] DEVELOPMENT AND VALIDATION OF A NOVEL NOMOGRAM TO PREDICT LYMPH NODE INVASION IN UPPER TRACT UROTHELIAL CARCINOMA
    Cesare, Saitta
    Jonathan, Afari A.
    Kevin, Hakimi
    Mimi, Nguyen, V
    Margaret, Meagher F.
    Luke, Wang
    Ithaar, Derweesh H.
    Riccardo, Autorino
    Savio, Pandolfo
    Giuseppe, Chiarelli
    Firas, Abdollah
    Matthew, Davis
    Alex, Stephens
    Spencer, Bell H.
    Giuseppe, Simone
    Giovanni, Lughezzani
    Nicolo, Buffi M.
    Gabriele, Tuderti
    Matteo, Ferro
    Courtney, Yong
    Chandru, Sundaram P.
    Marco, Tozzi
    Jacob, Taylor
    Vitaly, Margulis
    Enrico, Checcucci
    Francesco, Porpiglia
    Erika, Wood
    Alireza, Ghoreifi
    Hooman, Djaladat
    Wang Linhui
    Benjamine, Eilender M.
    Reza, Mehrazin
    Mark, Gonzalgo L.
    Dinno, Mendiola F.
    Wu Zhenjie
    Daniel, Eun D.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S103 - S103
  • [40] Development and validation of a novel nomogram to predict lymph node invasion in upper tract urothelial carcinoma
    Saitta, C.
    Meagher, M. F.
    Autorino, R.
    Porpiglia, F.
    Bell, S.
    Abdollah, F.
    Simone, G.
    Yong, C.
    Lughezzani, G.
    Afari, J.
    Tozzi, M.
    Jacob, T.
    Ghoreifi, A.
    Wang, L.
    Margulis, V
    Sundaram, C.
    Djaladat, H.
    Mehrazin, R.
    Gonzalgo, M.
    Buffi, N.
    Wu, Z.
    Ferro, M.
    Derweesh, I
    EUROPEAN UROLOGY, 2024, 85 : S716 - S717